Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
For this specific Request for Proposals, applications are sought to support education and/or quality improvement initiatives that focus on addressing challenges relating to the management of adults with uncontrolled acromegaly.
Multi-disciplinary collaborations, are encouraged when appropriate, but all partners must have a relevant role.
It is expected that projects will be evidence-based (education and/or quality improvement) and the proposed research/evaluation will follow generally accepted scientific principles. During review the intended outcome of the project is given careful consideration and, if appropriate based on the project goal, projects with the maximum likelihood to directly impact patient care will be given high priority.
Funding & Duration
Individual projects requesting up to USD $120,000 (approx. AUD $169,000) will be considered.
Anticipated Project Start and End Dates: October 2019 to October 2021.
Clinical research projects will not be supported. Projects evaluating the efficacy of therapeutic or diagnostic agents will not be considered.
Submission Requirements & Due Date
- Applications must be submitted for internal review by 11 June 2019
- Please email firstname.lastname@example.org if you are considering applying for this scheme.
- See also: Submitting an Application to Research Services for Review